MINAPHARM Pharmaceuticals Stock Price

MINAPHARM Pharmaceuticals produces medicines, chemicals, medical and dental supplies, cosmetics, veterinary and herbal medicines, and dietary supplements in Egypt and internationally. It operates through Biological Production, Drug Production, and Other Pharmaceuticals segments. The company provides its products for the treatment of acne, alopecia, analgesics and anti-inflammation, atopic dermatitis, autoimmune disease, bone health, cardiovascular, cerebral insufficiency, diabetic neuropathy and retinopathy, dyslipidemia, gastroenterology and hepatology, glaucoma, hematoma and thrombosis, hemorrhoids, haemostasis, immuno-stimulants and immunomodulatory, and infertility, as well as for iron deficiency anemia, labour induction, menopause, nausea and vomiting, ocular infection and inflammation, osteoporosis, post operative management, pregnancy and lacation, probiotic and gut health, psoriasis, respiratory tract infection, rheumatoid arthritis, supplements, topical antibiotics, topical muscle relaxant, and venous disease. MINAPHARM Pharmaceuticals was founded in 1958 and is headquartered in Cairo, Egypt.